VolitionRx Limited (NASDAQ:VNRX) Files An 8-K Results of Operations and Financial Condition

VolitionRx Limited (NASDAQ:VNRX) Files An 8-K Results of Operations and Financial Condition

Story continues below

Item2.02.

Results of Operations and Financial Condition.

The following information, including Exhibits 99.1 and 99.2, is
being furnished in accordance with General Instruction B.2. of
Form 8-K and shall not be deemed filed for purposes of Section 18
of the Securities Exchange Act of 1934, as amended (the Exchange
Act), or otherwise subject to the liabilities of that section,
nor shall it be deemed to be incorporated by reference in any
filing under the Securities Act of 1933, as amended (the
Securities Act), or the Exchange Act, except as expressly set
forth by specific reference in such filing:

As previously announced, on November 10, 2016, VolitionRx Limited
hosted a conference call discussing its financial results for the
quarter ended September 30, 2016. The conference call was
announced by a widely disseminated press release and was made
available to the public via audio webcast. Furnished herewith as
Exhibits 99.1 and 99.2 and incorporated by reference herein are
copies of the press release and a transcript of the conference
call, respectively.

Item 9.01.

Financial Statements and Exhibits.

(d)

Exhibits.

Exhibit

Number

Description

99.1

Press Release of VolitionRx Limited, dated November 10,
2016.

99.2

Transcript of Conference Call held on November 10, 2016.


About VolitionRx Limited (NASDAQ:VNRX)


An ad to help with our costs